Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. (Q45366170)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 March 2011

Language	Label	Description	Also known as
English	Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.	scientific article published on 11 March 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Janny Westdijk

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Debbie Brugmans

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Aart van't Oever

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Wilfried A M Bakker

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Lonneke Levels

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gideon Kersten

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

0 references

publication date

11 March 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

3390-3397

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Poliomyelitis eradication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Development of inactivated poliovirus vaccine derived from Sabin strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Immunogenicity of trypsin treated type 2 and type 3 poliovirus in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Standardization of Poliovirus Neutralizing Antibody Tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Determination of active concentrations and association and dissociation rate constants of interacting biomolecules: an analytical solution to the theory for kinetic and mass transport limitations in biosensor technology and its experimental verifica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.085

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.02.085

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21397718%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45366170&oldid=1562146812"